Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CV Risk”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Not applicableStudy completedNCT00648284
What this trial is testing

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

Who this might be right for
Type 2 Diabetes MellitusCV Risk
GlaxoSmithKline 1,100
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Post-approval studies (Phase 4)UnknownNCT00217178
What this trial is testing

Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)

Who this might be right for
AtherosclerosisCardiovascular Disease
Hamilton Health Sciences Corporation 900
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Not applicableEnrolling By InvitationNCT07363980
What this trial is testing

Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid ArthritisAtherosclerotic Ischemic DiseasePulmonary Disease+14 more
Ellen Margrethe Hauge 4,000
Not applicableStudy completedNCT01630928
What this trial is testing

Renal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-Factors

Who this might be right for
Hypertension, Resistant to Conventional Therapy
University Hospital of North Norway 50
Large-scale testing (Phase 3)Study completedNCT02104817
What this trial is testing

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Who this might be right for
Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
AstraZeneca 13,078
Not applicableStudy completedNCT00921752
What this trial is testing

C2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)

Who this might be right for
Cardiovascular Risk
AstraZeneca 1,500
Post-approval studies (Phase 4)Study completedNCT00327418
What this trial is testing

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Who this might be right for
Major Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more
Pfizer 2,800
Not applicableStudy completedNCT07088718
What this trial is testing

Prediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims Data

Who this might be right for
Type 2 DiabetesMajor Adverse Cardiac EventsCardiovascular (CV) Risk
Brigham and Women's Hospital 44,671
Not applicableTemporarily pausedNCT01740739
What this trial is testing

Evaluation Using ClearView in Determining Association to the Cardiac Risk Factors

Who this might be right for
Cardiovascular DiseasesCoronary Artery Disease
Epic Research & Diagnostics, Inc. 60
Large-scale testing (Phase 3)Looking for participantsNCT05918861
What this trial is testing

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Who this might be right for
Acute Coronary Syndrome
DalCor Pharmaceuticals 2,000
Not applicableUnknownNCT04359927
What this trial is testing

Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry

Who this might be right for
Sars-CoV2Covid19Cardiovascular Diseases+1 more
Hospital Clinic of Barcelona 4,538
Not applicableUnknownNCT05948969
What this trial is testing

Transform CV Risk in Diabetes

Who this might be right for
Type 2 Diabetes
American College of Cardiology 750
Not applicableStudy completedNCT00680082
What this trial is testing

Observational Usage Study of Statins in Primary Care in France

Who this might be right for
Healthy
AstraZeneca 2,100
Not applicableUnknownNCT01236820
What this trial is testing

A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients

Who this might be right for
Cardiovascular DiseaseChronic Kidney Disease PatientsHemodialytic Patients+2 more
China Medical University Hospital 48
Large-scale testing (Phase 3)Study completedNCT00799903
What this trial is testing

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Who this might be right for
Atherosclerosis
GlaxoSmithKline 15,828
Not applicableNot Yet RecruitingNCT07427589
What this trial is testing

Prospective Evaluation of New Metrics to Assess Cardiovascular Remodeling in Obstructive Sleep Apnea

Who this might be right for
Obstructive Sleep ApneaCardiovascular (CV) Risk
University Hospital, Antwerp 270
Not applicableStudy completedNCT01853839
What this trial is testing

Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients

Who this might be right for
Hypertension
Boehringer Ingelheim 1,674
Not applicableLooking for participantsNCT05693857
What this trial is testing

Perceive and Calculated CV Risk

Who this might be right for
Patient-Perceived Versus
Chinese University of Hong Kong 1,500
Load More Results